Access this stock data via API
Subscribe
CanSino Biologics Inc.
0
0
0%

Financials

Income statement

Fundamentals currency is CNY
Fiscal date Jun 2024 Mar 2024 Dec 2023 Sep 2023
Total reported revenue 188.8M 126.1M 185.3M 154.5M
Cost of revenue 57.4M 51.0M 1.1B -624.9M
Gross profit 131.4M 75.1M -960.5M 779.4M
Operating expense
Research & development 98.4M 106.7M 192.7M 123.3M
Selling general and admin 169.6M 51.4M 290.8M 112.8M
Other operating expenses 43.1M 40.0M
Operating income -67.8M -116.7M -1.3B 487.9M
Non operating interest income
Income 17.0M 25.9M 27.2M 23.5M
Expense 19.9M 16.2M 19.9M 16.7M
Other income expense
Pretax income -59.9M -193.0M -571.3M -172.7M
Tax provision 1.1M 0 -11.2M 179
Net income -61.0M -193.0M -560.1M -172.7M
Basic EPS -0.7
Diluted EPS -0.7
Basic average shares 272.0M
Diluted average shares 272.0M
EBITDA 15.6M -157.9M -1.5B 684.7M
Net income from continuing op.
Minority interests -129 5.3M 16.2M 29.1M
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 4 hours 59 minutes

11:00
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
09:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 16:10
All times are displayed in the Asia/Hong_Kong timezone (HKT, UTC+08:00).